Navigation Links
Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting
Date:6/5/2009

Akaza Research CEO will be presenting at the upcoming DIA annual meeting. In addition, Akaza Research will be be exhibiting OpenClinica, the popular open source clinical trials software.

Cambridge, MA (PRWEB) June 5, 2009 -- Akaza Research is pleased to announce that Chief Executive Officer Cal Collins will deliver a presentation at the Drug Information Association's (DIA's) 45th Annual Meeting, June 21-25, in San Diego, CA. The session, titled "Utilizing and Integrating Open Source Software in Clinical Research Environments," will explore how open source, standards-based software can improve flexibility, interoperability, and cost in clinical trials.

At the event Akaza Research will also be exhibiting OpenClinica, its flagship open source clinical trials software product for electronic data capture (EDC) and clinical data management in. Personnel from Akaza Research will be on-hand to demonstrate OpenClinica and answer questions.

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates data collection via electronic case report forms (eCRFs), and provides tools for data management and productive monitoring of clinical trials. OpenClinica supports leading CDISC standards and is designed to be compliant with industry and government regulations and guidelines such as 21 CFR Part 11, GCP, and HIPAA. OpenClinica is professionally supported by Akaza Research and has a worldwide open source community of over 6,000 users and developers. All versions of OpenClinica are freely available for download and use from http://www.op
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
2. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
6. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
9. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... LIBREVILLE, Gabon, December 2 ,...yone,s Problem and Heritage" , Coinciding...June 2010 the,Gabonese Republic is hosting an inte...issue of safeguarding biological resources in Afri...and state leaders, ministers,scientific experts, ...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Ltd ...al JAK2 inhibitor, SB1518, at The American Society...in New Orleans. ,, Data will be presented on th...n trial of SB1518 detailing its safety, tolerabili...file in dose levels ranging from 100 to 600 mg. Th...
(Date:12/2/2009)... SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world... in turmoil and uncertainty is part of many,busine...industry has been,relatively immune to the economi...n. , During the midst of the difficult ti...mp; Johnson inaugurated an R&D center in Shang...
(Date:12/1/2009)...NE VILLAGE, Nev., Dec. 1 ...announced revenue guidance for the fourth quarter ...on, as compared with $69 million for the fourth qu...ults was the first of two installment payments of ...th quarter 2008 results was a one-time $1.8 millio...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...ARUP Laboratories, a national,clinical and anatomi...nnovative laboratory research and development, ann...up purchasing agreement with Premier Purchasing,Pa...ng alliances of leading,hospitals and health care ... between ARUP and Premier which has been in effect...
...anoLogix, Inc. (OTC:,NNLX) is pleased to announce ...s Director of Intellectual Property. In addition, ...made in the rapid detection of,Anthrax utilizing t... has over seven years, experience as an intellectu...ndustries including the position of,Corporate Inte...
...27 Notice is hereby,given that the 2007 Annual Ge...olders of Rosetta Genomics Ltd. (NASDQ:ROSG) (the ...e offices of Yigal Arnon & Co., Azrieli,Center, Ro... September 24,2007, at 11:00 a.m. (Israel time) fo...ntment of Kost, Forer, Gabbay & Kasierer (a,member...
Other Biology Technology:ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services 2NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection 2NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection 3Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007 2
(Date:12/3/2009)...evels for the past three years in the troposphere ... area near Valladolid. The results, which are the ... that the levels rose "significantly" between 2002...eteorologists have been trying to find out about c...lved in the troposphere over various urban and rur...
(Date:12/3/2009)...U.S. Department of Energy,s (DOE) Brookhaven Natio... Institute of Science has made a major step in und...ation in DNA that is necessary to carry out import...in the December 1, 2009 edition of Nature Structu...ins responsible for interacting at specific sites ...
(Date:12/2/2009)...dhand cigarette smoke have an increased risk of de...ver smoked. , Results of this study are publish...n , a journal of the American Association for Canc... the December issue. , This year alone, more th...ancer; more than 159,000 will die from it and some...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Researcher awarded 241 2 million grant to study centrosomes and cilia 10038 1Researcher awarded 241 2 million grant to study centrosomes and cilia 10038 2Red Cross Sheltering Those Hit by Floods in Southeast 58051 1Red Cross Sheltering Those Hit by Floods in Southeast 58051 2Report Finds Significant Job Opportunities for Californians in Allied Health 3B Questions States Education Capacity To Train Workers 58049 1Report Finds Significant Job Opportunities for Californians in Allied Health 3B Questions States Education Capacity To Train Workers 58049 2Report Finds Significant Job Opportunities for Californians in Allied Health 3B Questions States Education Capacity To Train Workers 58049 3
...e scientists have completed a study on a beetle th...as now attacked 67 percent of the oak trees in an ...pears in the current issue of The Pan-Pacific Ent...d-boring beetle so rare it does not even have an a...Entomological Society of America common names comm...
... creationism are often shaped by what they learned...o a University of Minnesota study published in the...rican Institute of Biological Sciences. , Co-auth...he College of Biological Sciences, surveyed 1,000 ...e University of Minnesota to learn how biology maj...
... sleep deprivation. Sam Ridgway from the US Navy M...o send half of their brains to sleep while the oth...ls seem to be able to remain continually vigilant ...ay and his colleagues from San Diego and Tel Aviv ...vigilance tired them and took a toll on the animal...
Other Biology News:New Southern California beetle killing oaks 2U of Minnesota study finds high school teachers influence student views of evolution & creationism 2Dolphins maintain round-the-clock visual vigilance 2
...con's 3243 provides all the materials necessary fo...use in CMV antigen studies analysis. Kit Componen...22) One bottle containing 220 mL of buffered ammon...(Catalog No. 5113) One bottle containing 220 mL of...
Rabbit Anti-NO-TRYPTOPHAN CONJUGATE Polyclonal Antibody, Unconjugated from AbD Serotec
Goat Anti-Human SLI Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-L-DIHYDROXYPHENYLALANINE (L-DOPA) CONJUGATE Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: